Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Tolerogenic Dendritic Cells as a Therapeutic Strategy for the Treatment of Multiple Sclerosis Patients (TOLERVIT-MS)

Fundació Institut Germans Trias i Pujol · 2017
ClinicalTrials.gov · Datasets · License: Public Domain · 2017
Open Source ↗
dendritic-cellsmultiple-sclerosis
multiple sclerosis, relapsing-remitting, multiple sclerosis, chronic progressive, multiple sclerosis, dendritic cells, immune tolerance, myelin proteins, tolerogenic dendritic cells, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 864055
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.